Oncologist in My Pocket: What the Hospice & Palliative Provider Needs to Know About Hematology/Oncology (P16)


      • Verbalize the need for increased knowledge of topics in Hematology/Oncology.
      • Define and describe the language and assessment tools utilized by Hematologist/Oncologists.
      • Describe available treatment and prognosis for advanced solid tumor malignancies including chemotherapy, immunotherapy and targeted treatments.
      Hospice and palliative care (HPC) providers are increasingly called upon to care for patients receiving active treatment of hematologic or oncologic malignancies because of growing evidence that early palliative care improves survival, symptoms, mood, cost, and patient satisfaction. HPC providers may care for these patients on hospital consultation services, in outpatient clinics, and in home hospice or palliative care services. The need for upstream palliative care has resulted in the development of innovative models by private insurance companies and a demonstration project by the Center for Medicare and Medicaid Services. To ensure success of these models, and encourage upstream involvement, it is imperative that HPC providers can competently care for the patients in question. Current hospice & palliative training and certification does not necessarily ensure competency in all essential areas. In fact, providers may not have had any direct exposure to hematology/oncology care before entering the field while at the same time, care of patients with hematologic or oncologic malignancies is increasingly complex. Novel therapies emerge rapidly with mechanisms and side effects that are different from traditional chemotherapy and allow for treatment of patients with more limited performance status. This has resulted in attendees of the AAHPM annual meeting repeatedly requesting sessions to keep up-to-date on topics in hematology/oncology. This workshop will ensure providers are equipped with the essentials needed to approach the care of these patients, including: terminology, treatment options, unique aspects of targeted therapies, hematology/oncology emergencies, hospice coverage of cancer care, expected side effects of treatments and navigating relationships with hematologists/oncologists.
      Upon completion of this workshop, hospice and palliative providers will have the necessary tools to develop an approach to the care of patients with hematologic or oncologic malignancies at any point along their cancer trajectory.